Clinical Trials Directory

Trials / Completed

CompletedNCT06129513

The Effect of a Plant-blend Protein Isolate on Post-exercise Myofibrillar Protein Synthesis

The Effect of a Novel Plant-blend Protein Isolate on Post-exercise Myofibrillar Protein Synthesis When Compared to Whey Protein in Healthy Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Exeter · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Dietary protein ingestion is required to maximise the anabolic response during the recovery from resistance exercise. Whey protein is considered the optimal dietary strategy to maximise post-exercise muscle protein synthesis, but animal-protein production and consumption is associated with growing environmental and ethical concerns. Plant-based protein sources are considered of lesser anabolic quality than isonitrogenous boluses of animal-derived protein attributed to, at least in part, deficiencies in key essential amino acid. Blending different protein sources may overcome amino acid deficiencies and potentiate the post-exercise anabolic response. In the present study the investigators assessed the post-exercise muscle protein synthetic response following the ingestion of a novel plant-based protein isolate when compared with an isonitrogenous bolus of whey protein in healthy young, resistance trained women and men.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBilateral resistance exerciseA bout of bilateral resistance exercise consisting of barbell back squat, leg leg press and leg extension
DIETARY_SUPPLEMENTWhey proteinFollowing execution of bilateral resistance exercise, participants will ingest 32 g protein from whey protein isolate
DIETARY_SUPPLEMENTPlant-blend proteinFollowing execution of bilateral resistance exercise, participants will ingest 32 g protein from plant-blend protein isolate

Timeline

Start date
2022-02-24
Primary completion
2022-10-31
Completion
2022-10-31
First posted
2023-11-13
Last updated
2023-11-13

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06129513. Inclusion in this directory is not an endorsement.